NASDAQ | ETF
The fund invests at least 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 6.54% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 5.84% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.87% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 4.59% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.48% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 4.23% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.13% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.93% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.67% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.65% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.62% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.62% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.47% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 3.33% |
| 1548 | Genscript Biotech Corp | Healthcare | Biotechnology | 3.00% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 2.88% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 2.32% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.31% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.10% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.06% |